Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1750 participants
OBSERVATIONAL
2023-10-31
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions the investigators aim to answer are:
* What is the perceived burden of tobacco use and AP exposure among adolescents?
* What are the contextual drivers and behavioral determinants contributing to (prevention of) these risk factors?
* How do the dynamics between stakeholders influence prevention efforts?
In this study, data will be collected through interviews, focus group discussions, photovoice, document analysis, observations, personal exposure monitoring, and questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevent Exposure to Tobacco Smoke at Home [Gesunde Atemluft zu Hause]
NCT00647413
Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children
NCT06723470
Reduction of Exposure, Inflammation, and Oxidative Stress Following At Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
NCT05385055
Implementing an Adapted Smoke-free Homes Intervention in Spain
NCT06932276
A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools
NCT02544360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Family members: relatives in the first or second degree of (not necessarily participating) adolescents;
* Providers: any relevant stakeholder that is connected to adolescents through profession (e.g. school teacher, youth worker) and/or providers of (public) healthcare;
* Stakeholders: any relevant stakeholder with either a specific expertise, in-depth knowledge or overall overview on the subject, and in direct contact with the community (e.g. community member/leader, policy maker). Due to the community- and individual-level focus of this research, individuals associated with the tobacco industry are deliberately not included as stakeholders.
Exclusion Criteria
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
University of York
OTHER
University of Edinburgh
OTHER
The Initiative
UNKNOWN
Lungs Europe
UNKNOWN
International Primary Care Respiratory Group
UNKNOWN
University of Groningen
OTHER
University of Crete
OTHER
Ministry of Health, Kyrgyzstan
OTHER_GOV
Romanian Center for Studies in Family Medicine
UNKNOWN
Makerere University
OTHER
Leiden University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rianne MJJ van der Kleij, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rianne MJJ van der Kleij, PhD
Role: PRINCIPAL_INVESTIGATOR
Leiden University Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101095461
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
10063681; 10060974; 1006440
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
23-3075
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.